Isma N., Barani J., Mattiason I., Lindblad B., Gottsäter A.Lipid-lowering therapy is related to inflammatory markers and 3-year mortality in patients with critical limb ischemia [published online ahead of print April 2, 2008]. Angiology. doi:10.1177/0003319707306144.
2.
Landi F., Onder G., Gambassi G., Pedone C., Carbonin P., Bernabei R.Body mass index and mortality among hospitalized patients. Arch Intern Med. 2000;160: 2641-2644.
3.
Volpato S., Palmieri E., Fellin R., Zuliani G.Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology. 2000;46:22-27.
4.
Heart Protection StudyCollaborative Group.Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007; 45:645-654.
